McKesson (MCK) Gets a Hold Rating from Morgan Stanley


In a report released today, Ricky Goldwasser from Morgan Stanley maintained a Hold rating on McKesson (MCK), with a price target of $130. The company’s shares closed on Friday at $124.50, close to its 52-week low of $117.19.

According to TipRanks.com, Goldwasser is a 3-star analyst with an average return of 3.0% and a 56.2% success rate. Goldwasser covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Quest Diagnostics Inc, and Charles River Labs.

Currently, the analyst consensus on McKesson is a Moderate Buy with an average price target of $139.57.

See today’s analyst top recommended stocks >>

McKesson’s market cap is currently $24.32B and has a P/E ratio of 204.70. The company has a Price to Book ratio of 2.61.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts